Seeking Alpha

While Pfizer's (PFE) and J&J's (JNJ) bapineuzumab Alzheimer's drug failed in a Phase III...

While Pfizer's (PFE) and J&J's (JNJ) bapineuzumab Alzheimer's drug failed in a Phase III trial of people who already exhibit symptoms, scientists may yet test it on those at risk of the disease but aren't yet affected. Pfizer and J&J, though, don't yet have plans to assess bapineuzumab for this purpose.
From other sites
Comments (2)
  • Goeleven
    , contributor
    Comments (629) | Send Message
     
    First t(ime that I here from Bapinuzumab!?
    8 Aug 2012, 03:42 PM Reply Like
  • Goeleven
    , contributor
    Comments (629) | Send Message
     
    Wait and see
    8 Aug 2012, 03:44 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs